Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Elisangela da Costa Lima"'
Autor:
Cristiane de Cássia Bergamaschi, Luciane Cruz Lopes, Izabela Fulone, Mabel Fernandes Figueiró, Lauren Giustti Mazzei, Jardel Corrêa de Oliveira, Luis Phillipe Nagem Lopes, Elisangela da Costa Lima, Flávia Casale Abe
Publikováno v:
BMJ Open, Vol 13, Iss 6 (2023)
Introduction Atypical antipsychotics have been studied to treat autism spectrum disorder (ASD). However, like little is known about whether these drugs are effective and safe when compared in controlled and non-controlled settings. This study aims to
Externí odkaz:
https://doaj.org/article/efcec129534746aebbfa04a656a7b902
Autor:
Elisangela da Costa Lima, Thais de Barros Fernandes, Adair Freitas, Juliana Freire de Lima Sias, Marcelo Gerardin Poirot Land, Mariana Tschoepke Aires, Louise Bracken, Matthew Peak
Publikováno v:
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Children are more vulnerable to adverse drug reactions (ADRs) due to complex changes in the body during the growth process and lack specific pharmacoepidemiologic studies. Causality and Avoidability assessment of ADRs are relevant
Externí odkaz:
https://doaj.org/article/2f829d8ba69e419087b7dcf0966b44b2
Autor:
Lisiane Freitas Leal, Claudia Garcia Serpa Osorio-de-Castro, Luiz Júpiter Carneiro de Souza, Felipe Ferre, Daniel Marques Mota, Marcia Ito, Monique Elseviers, Elisangela da Costa Lima, Ivan Ricardo Zimmernan, Izabela Fulone, Monica Da Luz Carvalho-Soares, Luciane Cruz Lopes
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Background: In Brazil, studies that map electronic healthcare databases in order to assess their suitability for use in pharmacoepidemiologic research are lacking. We aimed to identify, catalogue, and characterize Brazilian data sources for Drug Util
Externí odkaz:
https://doaj.org/article/158c779266e3494382d1adbafb1bba54
Autor:
Elisangela da Costa Lima, Guacira Corrêa de Matos, Jean M. de L. Vieira, Ivana C. da C.R. Gonçalves, Lucio M. Cabral, Mark A. Turner
Publikováno v:
Jornal de Pediatria (Versão em Português), Vol 95, Iss 6, Pp 682-688 (2019)
Objective: To assess spontaneous reports of suspected adverse drug reactions in children aged 0‐12 years from the Brazilian Health Regulatory Agency between 2008 and 2013. Methods: A cross‐sectional study on suspected adverse drug reactions repor
Externí odkaz:
https://doaj.org/article/19fa3d64b932400db866dea12e862814
Autor:
Elisangela da Costa Lima, Barbara Dias Camarinha, Nathalia Cristina Ferreira Bezerra, Anderson Gonçalves Panisset, Raquel Belmino de Souza, Marcus Tolentino Silva, Luciane Cruz Lopes
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Children are exposed to drug-drug interactions (DDI) risks due to their organism’s complexity and the need for several medicines prescriptions in pediatric intensive care units (PICU). This study aimed to assess the prevalence of potential DDIs in
Externí odkaz:
https://doaj.org/article/6dc6d8fccfd747238fc337b4eeafa9a4
Autor:
Jean Mendes de Lucena Vieira, Guacira Corrêa de Matos, Fabrício Alves Barbosa da Silva, Louise E. Bracken, Matthew Peak, Elisangela da Costa Lima
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Children are more exposed to inappropriate medicine use and its consequent harms. Spontaneous reporting of suspected Serious Adverse Drug Reactions (SADR) increases knowledge and prevention of pharmacotherapy risk. Disproportionality measures are use
Externí odkaz:
https://doaj.org/article/0ae97ac999fe4a8cbc626d8e7db453c9
Autor:
Ricardo Eccard da Silva, Elisangela da Costa Lima, Maria Rita C. G. Novaes, Claudia G. S. Osorio-de-Castro
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundBrazilian patients have legal right to access unlicensed medicines undergoing clinical research, if there is evidence of efficacy and safety. This study investigated the occurrence of serious adverse events related to very high-cost medicin
Externí odkaz:
https://doaj.org/article/5c87158b64934e6ba3b6d0e19f7053bf
Autor:
Elisangela da Costa Lima
Publikováno v:
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 8, Iss 1 (2019)
A notificação de reações adversas a medicamentos (RAM) é um componente importante para a qualidade do cuidado nos hospitais, valorizada em programas de acreditação1,2, uma vez que as RAM estão claramente envolvidas na avaliação da seguran
Externí odkaz:
https://doaj.org/article/334deaf5416a4acaaebd150771a7cb8e
Publikováno v:
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 6, Iss 4 (2019)
A tradução dos resultados da pesquisa médica para as práticas clínicas nos serviços é um dos maiores desafios enfrentados pelos sistemas sanitários1,2. Para preencher esta lacuna, a investigação translacional (IT) vem sendo ressaltada como
Externí odkaz:
https://doaj.org/article/5fc6459edf5a417abf5694cb186da14f
Publikováno v:
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 5, Iss 2 (2019)
É com alegria que assumo a editoria científica da RBFHSS a partir deste número, dando continuidade ao trabalho de Helaine Carneiro Capucho. A confiança depositada na RBFHSS por autores, corpo editorial, colaboradores e leitores, fomentada em sua
Externí odkaz:
https://doaj.org/article/27148a60060a46b095b4ec64ffd578e1